Sputnik Light Covid-19 vaccine likely to get nod for Phase-3 trials in India

Guwahati, September 15 (NKTV): The Drugs Controller General of India’s (DCGI) will likely give approval to Dr Reddy’s Laboratories to conduct Phase-3 trials of Russian made single-dose Covid-19 vaccine Sputnik V Light in the country.

Earlier in July, the Central Drugs Standard Control Organisation’s expert committee did not grant permission for trials as it didn’t find a “scientific rationale” behind the same. According to reports Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V the world’s first registered vaccine against coronavirus.